Axcelis Technologies, Inc. Overbought in Morning Session
As of morning trading, Axcelis Technologies, Inc. (NASDAQ:$ACLS)’s current distance from 20-Day Simple Moving Average is 17.05%, standing 36.66% away from 50-Day Simple Moving Average while trading up 62.06% from the 200-Day Simple Moving Average. ... [Read]
Price Target Update on Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals, Inc. (NASDAQ:$SPPI) plundered a cool -2.43% with the closing price of $18.90 as of morning trading. The overall volume in the last trading session was 2.7 million shares. ROI is a form of ... [Read]
SunPower Corporation Registers a 2.84% Price Change After Morning Session
As of morning trading, SunPower Corporation (NASDAQ:$SPWR) stock saw a move of 2.84% with the closing price of $6.87. During the past week, the company saw a total shift of 1.93%. Over the last three ... [Read]
Head-to-Head: Axcelis Technologies VS Xcerra Corporation
When it comes to small-cap computer technology companies, Xcerra Corporation (NASDAQ:$XCRA) and Axcelis Technologies (NASDAQ:$ACLS) are two contenders. How do they stack up against each other, though? Let’s look at the stats of these two ... [Read]
Imperva, Inc. Expected to Report Upwards of $83.07 Million in Sales This Quarter
According to the Zacks Investment Research report, Equities analysts forecast that Imperva, Inc. (NYSE:$IMPV) will see sales of $83.07 million for the current quarter. Seven analysts have issued estimates for Imperva’s earnings. The lowest sales ... [Read]
Head-to-Head: Impax Laboratories VS. SCYNEXIS
Impax Laboratories (NASDAQ:$IPXL) and SCYNEXIS (NASDAQ:$SCYX) are both small-cap companies competing in the medical sector. So how do these two rivals stack up against each other? Let’s look at the numbers. Profitability Impax Laboratories has ... [Read]
Anavex Life Sciences Corp.: Top Holders Statistics
Anavex Life Sciences Corp. (NASDAQ:$AVXL) reached 75.36% versus a 1-year low price of $2.76. On October 20th, the stock was last seen 3.64% higher, reaching at $4.84. At the most recent session, Anavex shares are ... [Read]
SunPower Corporation’s Rating Lowered by Zacks Investment Research
In a report on Tuesday, Zacks Investment Research lowered their SunPower Corporation (NASDAQ:$SPWR) stock rating from ‘Buy’ to ‘Hold’. “SunPower is gradually shifting its revenue base from solar panel sales to the development of solar ... [Read]
Zacks Investment Research Upgrades VBI Vaccines, Inc. to ‘Hold’
A report on Tuesday from Zacks Investment Research upgraded VBI Vaccines (NASDAQ:$VBIV), Inc from a ‘Sell’ to a ‘Hold’ rating. VBI Vaccines is a biotechnology company that specializes in developing vaccines and antigens for issues ... [Read]
Is Impax Laboratories a Buy At $16?
Impax Laboratories (NASDAQ:$IPXL) currently has a going rate of $20.75 per share. This could be a shaky proposition for some investors. However, there may be another way to get in on the drug manufacturer’s stock. ... [Read]